期刊文献+

国产与进口紫杉醇治疗晚期非小细胞肺癌的临床疗效观察 被引量:2

下载PDF
导出
摘要 肺癌是常见恶性肿瘤,其中非小细胞肺癌(non-small celllung cancer,NSCLC)占绝大多数,患者一旦确诊,80%以上属于晚期。多项研究显示,紫杉醇等第三代化疗药物联合铂类药物是治疗晚期NSCLC的标准一线方案。
作者 陆朝云
出处 《实用癌症杂志》 2012年第3期301-302,共2页 The Practical Journal of Cancer
  • 相关文献

参考文献4

二级参考文献29

  • 1马锐,伞宝君.紫杉醇联合顺铂治疗晚期非小细胞肺癌的临床研究[J].临床肿瘤学杂志,2005,10(2):128-129. 被引量:14
  • 2李勇,张湘茹,孙燕.非小细胞肺癌的化疗进展[J].癌症进展,2006,4(4):333-341. 被引量:40
  • 3白取治ほか.c野义制药研究所论文报告集[C].,1992.2123.
  • 4禾田透ほか.c野义制药研究所论文报告集[C].,1993.2375.
  • 5户谷刂兢郅.c野义制药研究所论文报告集[C].,1992.2241.
  • 6小原收ほか.c野义制药研究所论文报告集[C].,1993.2374.
  • 7Lilenbaum RC,langenberg P,Dickersin K. Single agent yersus combination chemotherapy in patients with advanced non-small cell lung carcinoma[J]. Cancer, 1998,86 : 116.
  • 8Baggstrom M Q, Stinchcomebe T E, Fried D B, et al. Third-eneration chemotherapy agents in the treatment of advaneed non-small cell lung: a meta analysis[ J]. J Thorac Oneol,2007,2(9) :845.
  • 9Feliu J, Martin G, Madronal C, et al. Combination of low dose cisplatin and gemcitabine for treatment of elderly patients with advanced non- small-cell lung cancer [J]. Cancer Chemother Phar-macol, 2003,52 (3) :247.
  • 10Inuyama Y,Miyake H,Horiuchi M,et al.A late phase Ⅱ clinical study of cisdiammine glycolato platinum,254-S,for head and neck cancers[J].Gan To Kagaku Pyoho,1992,19(6):871-877.

共引文献120

同被引文献19

  • 1Giorgio CG,Pappalardo A,Russo A,et al.A phaseIIstudy of induction chemotherapy followed by con-current chemoradiotherapy in elderly patients with lo-cally advanced non -small -cell lung cancer .Anti-cancer Drugs.2007,18(6):713^719.
  • 2Gridelli C, Maione P, Rossi A,et al.Treatment oflocally advanced non -small -cell lung cancer in theelderly,Curr Opin Oncol.2005,17(2): 130-134.
  • 3Berghmans T,Lafitte JJ,Lecomte J,et al.Second -line paclitaxel in non-small cell lung cancer initiallytreated with cisplatima study by the European LungCancer Working Party. Br J Cancer .2007,96(11):1644.
  • 4Wang J,Yang B,Han L,Li X,Tao H,Zhang S,Hu Y.Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines. Cellular Physiology and Biochemistry . 2013
  • 5Aggarwal C,Li L,Borghaei H,et al.Multidisciplinary therapy of stageⅢA non-small-cell lung cancer:long-term outcome of chemoradiation with or without surgery. Cancer Control . 2013
  • 6Byron E,Pinder-Schenck M.Systemic and targeted therapies for early-stage lung cancer. Cancer Control . 2013
  • 7Kuykendall A,Chiappori A.Advanced EGFR mutation-positive non-small-cell lung cancer:case report,literature review,and treatment recommendations. Cancer Control . 2013
  • 8邝浩斌,黄冬生,吕江青,王维勇,盛青.多西紫杉醇联合卡铂治疗晚期非小细胞肺癌的疗效观察[J].临床肺科杂志,2010,15(1):3-4. 被引量:28
  • 9杨军礼,张秀春,袁霞妹,楼君,黄曙.姑息化疗EGFR-TKI治疗失败后晚期非小细胞肺癌临床疗效观察[J].实用肿瘤杂志,2011,26(1):55-58. 被引量:9
  • 10徐春华,谢海燕.非小细胞肺癌患者红细胞沉降率与生存期的相关性[J].新医学,2011,42(2):100-101. 被引量:1

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部